Nephro Care India Limited — Others, 06-01-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Nephro Care India Limited has announced a board meeting regarding the non-applicability of certain corporate governance regulations under SEBI (Listing Obligations and Disclosure Requirements) for companies listed on the SME Exchange. As the company listed on NSE EMERGE on July 5, 2024, it is exempt from specific governance provisions, allowing it to streamline operations. This update may have a neutral impact on investor sentiment, as it highlights the company's ongoing compliance focus while reducing governance burdens, potentially enhancing operational agility and shareholder interests.